Menu

ImmunityBio, Inc. IBRX

Full chart Compare
Set alert

Price alert · IBRX

All alert types
6.17 USD -0.50 (-7.57%)

Nov 12, 2026, 1:22 PM EST

6.10 Day range 6.50
1.95 52-week range 12.43
YTD
+211.36%
1 year
+199.27%

Discussion (3506)

Sign in to join the discussion

frank fager IBRX 5 months ago #1161

Stop with the squeeze F-ing fantasy

Email tip lines at MSM and try to get them to cover ImmunityBio

Member IBRX 5 months ago #1162

This will be trading above 9:00 in 6 min?. Your all welcome

frank fager IBRX 5 months ago #1163

We live in one the most corrupt countries on the planet. Why? We print massive amounts of money that can be miss used for power and control and be stolen in giant fraud schemes.

frank fager IBRX 5 months ago #1166

Just sent the MSM tip lines a email with all the recent links of news

I hate this fucking corrupt world

frank fager IBRX 5 months ago #1167

Think of how the share price would ? if MSM CNBC or FoxB featured ImmunityBio instead they black ball it.... why? Merck and BP spends billions on ads, the corruption of the media is so obvious. The pervasive corruption in America and the world is at a biblical level.

frank fager IBRX 5 months ago #1168

Why so long the F ing FDA made ImmunityBio run an additional trial to protect BP Merck and Keytruda. That was TFBS Anktiva and BCG Works equally well for all bladder cancer. But but 80% of bladder cancer is papillary to the fucking FDA protected Merck and Keytruda by only give a single approval. Greed Criminals. More FDA intrenched bureaucrats need to quit or be fired.

frank fager IBRX 5 months ago #1169

What's going on

Hedge funds and Wall Street trying to kill IBRX and preserve their investments in big pharma big healthcare

frank fager IBRX 5 months ago #1170

Soon ImmunityBio will be able to have an unlimited supply from Japan and India which will add to profits and no shortages to combine with Anktiva. Currently Merck controls, as the only manufacturer, the market for BCG and its use with Mercks Keytruda.

Anktiva will replace Keytruda and ImmunityBio will cut Mercks monopoly for BCG off too. Merck will lose 30-50 billion in sales